HTAi 2026 Post-Conference Evaluation Meeting Held
ARTED held HTAi 2026 Post-Conference Evaluation Meeting online on 9 July 2026, bringing together members to comprehensively review the key outcomes of the HTAi 2026 Annual Meeting, held in Istanbul from 6–10 June 2026 under the theme “HTA as a System Shaper.”
During the meeting, Ferda Bayşu, Assoc. Prof. Rabia Sucu, Prof. Esra Meltem Koç, and Prof. Haluk Özsarı shared their insights on the conference's most significant scientific sessions, panel discussions, and international experiences. Participants discussed the latest global developments in Health Technology Assessment (HTA), including value-based healthcare systems, AI-enabled health technologies, digital health, the use of real-world evidence in decision-making, early dialogue mechanisms, patient involvement, and emerging approaches to evaluating health technologies throughout their lifecycle.
In addition to the scientific programme, participants reflected on the organizational success of HTAi 2026, emphasizing that hosting the conference in Türkiye represented a significant achievement in terms of international visibility. The national consortium established to organize the conference was recognized for successfully bringing together diverse stakeholders around a common objective, ensuring effective coordination throughout the planning and implementation process. The conference was widely regarded as a success from both scientific and operational perspectives, providing a valuable model for future international healthcare events.
The distinguished speakers also highlighted best practices presented during the conference and shared recent developments in HTA systems across different countries. Discussions focused on how these experiences could contribute to strengthening Türkiye's health technology ecosystem, with particular emphasis on the importance of multidisciplinary approaches to the assessment of medical devices and digital health technologies, improving data quality in decision-making processes, and enhancing stakeholder engagement.
The meeting also explored the international collaborations established during HTAi 2026, potential areas for future joint initiatives, and opportunities to further strengthen ARTED's contribution to the advancement of Health Technology Assessment.
ARTED member companies that supported the conference as panel sponsors also shared their experiences, observations, and recommendations, providing valuable perspectives to help shape future international HTA initiatives.
The meeting concluded successfully, serving as an important platform for disseminating the knowledge gained at HTAi 2026, sharing international developments with ARTED members, and reinforcing a common vision for the future of Health Technology Assessment.
Looking ahead, ARTED will continue its evaluation and consultation process in preparation for future international HTA conferences and events. Building on the experience and outcomes of HTAi 2026, the Association will continue exploring new collaboration opportunities and promoting initiatives that contribute to the advancement of the health technology ecosystem.